Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein
- PMID: 16725170
- DOI: 10.1016/j.virol.2006.04.012
Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein
Abstract
The transmembrane subunit (gp41) of the HIV Env glycoprotein contains conserved neutralizing epitopes which are not well-exposed in wild-type HIV Env proteins. To enhance the exposure of these epitopes, a chimeric protein, HA/gp41, in which the gp41 of HIV-1 89.6 envelope protein was fused to the C-terminus of the HA1 subunit of the influenza HA protein, was constructed. Characterization of protein expression showed that the HA/gp41 chimeric proteins were expressed on cell surfaces and formed trimeric oligomers, as found in the HIV Env as well as influenza HA proteins. In addition, the HA/gp41 chimeric protein expressed on the cell surface can also be cleaved into 2 subunits by trypsin treatment, similar to the influenza HA. Moreover, the HA/gp41 chimeric protein was found to maintain a pre-fusion conformation. Interestingly, the HA/gp41 chimeric proteins on cell surfaces exhibited increased reactivity to monoclonal antibodies against the HIV Env gp41 subunit compared with the HIV-1 envelope protein, including the two broadly neutralizing monoclonal antibodies 2F5 and 4E10. Immunization of mice with a DNA vaccine expressing the HA/gp41 chimeric protein induced antibodies against the HIV gp41 protein and these antibodies exhibit neutralizing activity against infection by an HIV SF162 pseudovirus. These results demonstrate that the construction of such chimeric proteins can provide enhanced exposure of conserved epitopes in the HIV Env gp41 and may represent a novel vaccine design strategy for inducing broadly neutralizing antibodies against HIV.
Similar articles
-
Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.PLoS One. 2011;6(5):e14813. doi: 10.1371/journal.pone.0014813. Epub 2011 May 19. PLoS One. 2011. PMID: 21625584 Free PMC article.
-
DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.Virology. 2004 Oct 25;328(2):292-300. doi: 10.1016/j.virol.2004.07.031. Virology. 2004. PMID: 15464849
-
Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles.J Virol. 2004 Aug;78(15):8342-8. doi: 10.1128/JVI.78.15.8342-8348.2004. J Virol. 2004. PMID: 15254206 Free PMC article.
-
A new paradigm in molecular recognition? Specific antibody binding to membrane-inserted HIV-1 epitopes.J Mol Recognit. 2011 Jul-Aug;24(4):642-6. doi: 10.1002/jmr.1092. J Mol Recognit. 2011. PMID: 21584875 Review.
-
Broadly neutralizing antibodies against HIV-1: templates for a vaccine.Virology. 2013 Jan 5;435(1):46-56. doi: 10.1016/j.virol.2012.10.004. Virology. 2013. PMID: 23217615 Review.
Cited by
-
Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.PLoS One. 2011;6(5):e14813. doi: 10.1371/journal.pone.0014813. Epub 2011 May 19. PLoS One. 2011. PMID: 21625584 Free PMC article.
-
Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope.J Virol. 2009 May;83(10):5087-100. doi: 10.1128/JVI.00184-09. Epub 2009 Mar 11. J Virol. 2009. PMID: 19279101 Free PMC article.
-
A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity.Int J Mol Sci. 2022 Nov 8;23(22):13716. doi: 10.3390/ijms232213716. Int J Mol Sci. 2022. PMID: 36430190 Free PMC article.
-
Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.J Virol. 2012 Mar;86(6):2930-41. doi: 10.1128/JVI.06349-11. Epub 2012 Jan 11. J Virol. 2012. PMID: 22238313 Free PMC article.
-
Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein.J Biomed Sci. 2014 Aug 27;21(1):79. doi: 10.1186/s12929-014-0079-x. J Biomed Sci. 2014. PMID: 25160824 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials